Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
Percipient Capital
LondonSeed–Late Stage$1.3M – $6.3M
3 people
SBCVC
TortolaSeed–Late Stage
6 people
Waterman Ventures
UtrechtSeed–Late Stage
3 people
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
QB Capital
FukuokaPre-Seed–Growth
8 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
TRICAPITAL
Scottish BordersSeed–Growth$315K – $2.5M
2 people
Split Rock Partners
Eden PrairieSeed–Late Stage$2M – $40M
4 people
Happiness Capital
Hong KongSeed–Growth
6 people
Dementia Discovery
LondonPre-Seed–Series C
6 people
TPB
San FranciscoSeed–Late Stage
6 people
Development Bank of Wales
CardiffPre-Seed–Late Stage$12.7K – $12.7M
10 people
University Associates Venture Capital
TucsonSeed–Growth
4 people
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
Seventure Partners
ParisSeed–Growth
5 people
Axil Capital
TokyoSeed–Late Stage
7 people
DC Investment Partners
McLeanSeed–Late Stage$10M
7 people
DCI Partners Co. Ltd.
TokyoPre-Seed–Growth$4.3M – $71M
4 people
Med-Fine Capital
ShanghaiSeed–Late Stage
7 people
Muirwoods Ventures
SeoulSeed–Late Stage
PRIVEQ Capital Funds
TorontoSeed–Growth
3 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.

















































